Sage Rhino Capital LLC Acquires New Position in Molina Healthcare, Inc $MOH

Sage Rhino Capital LLC acquired a new stake in Molina Healthcare, Inc (NYSE:MOH) in the first quarter, HoldingsChannel.com reports. The fund acquired 2,295 shares of the company’s stock, valued at approximately $306,000.

Other institutional investors have also bought and sold shares of the company. Torren Management LLC purchased a new position in Molina Healthcare during the fourth quarter worth approximately $26,000. Miller Global Investments LLC purchased a new stake in Molina Healthcare in the 4th quarter valued at $27,000. MUFG Securities EMEA plc purchased a new stake in Molina Healthcare in the 2nd quarter valued at $48,000. Cromwell Holdings LLC increased its stake in shares of Molina Healthcare by 211.9% in the 4th quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock worth $32,000 after acquiring an additional 125 shares during the last quarter. Finally, Quarry LP acquired a new stake in shares of Molina Healthcare in the 4th quarter worth $32,000. 98.50% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Molina Healthcare

In other Molina Healthcare news, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $191.55, for a total transaction of $114,930.00. Following the completion of the sale, the chief accounting officer directly owned 12,815 shares in the company, valued at $2,454,713.25. This trade represents a 4.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Jeff D. Barlow sold 17,811 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the completion of the sale, the insider directly owned 67,175 shares in the company, valued at $12,502,611. This trade represents a 20.96% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 1.44% of the company’s stock.

Molina Healthcare Trading Up 1.6%

MOH stock traded up $3.70 during midday trading on Tuesday, hitting $231.40. 136,042 shares of the company’s stock were exchanged, compared to its average volume of 1,499,607. Molina Healthcare, Inc has a 1-year low of $121.06 and a 1-year high of $237.50. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.97. The stock has a market capitalization of $12.06 billion, a PE ratio of 68.41 and a beta of 0.74. The business has a 50-day simple moving average of $195.46 and a two-hundred day simple moving average of $171.20.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, beating the consensus estimate of $1.57 by $0.78. The business had revenue of $10.80 billion for the quarter, compared to analyst estimates of $10.91 billion. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The company’s quarterly revenue was down 3.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $6.08 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, sell-side analysts predict that Molina Healthcare, Inc will post 5.23 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on MOH shares. Morgan Stanley boosted their price target on shares of Molina Healthcare from $146.00 to $167.00 and gave the company an “equal weight” rating in a research report on Thursday, June 4th. JPMorgan Chase & Co. raised their price objective on shares of Molina Healthcare from $169.00 to $191.00 and gave the stock a “neutral” rating in a research report on Monday, June 8th. Zacks Research raised shares of Molina Healthcare from a “strong sell” rating to a “hold” rating in a research note on Monday, April 20th. Bank of America upgraded shares of Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 target price on the stock in a report on Wednesday, April 29th. Finally, UBS Group increased their price target on shares of Molina Healthcare from $180.00 to $202.00 and gave the company a “neutral” rating in a research note on Friday, May 22nd. Three equities research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $184.81.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.